CanadaErythromycin Ophthalmic Ointment USP (Steri‑Med Pharma Inc.), DIN 02326663, strength 5 mg/g, in lots 2024K02 and 2024J04 is being recalled in Canada; you can identify affected product by the brand, DIN, strength and lot numbers. The recall was issued because the sterility of the product might be compromised. Verify whether your product is affected, consult your healthcare provider before discontinuing use, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: STERI-MED PHARMA INC., 242, Rue Saint-Cyrille Ouest, Upton, QC, J0H 2E0.
How to identify it
Brand: STERI-MED PHARMA INC.; Product Name: ERYTHROMYCIN OPHTHALMIC OINTMENT USP; Market Authorization: DIN 02326663; Dosage Form: Ointment; Strength: ERYTHROMYCIN 5 MG/G; Lot: 2024K02, 2024J04
The hazard
The sterility of the product might be compromised in the affected lots.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)